Mark D. Young, Ph.D. has been named senior vice president of Pharmaceutical Operations at Alder Biopharmaceuticals. Dr. Young brings more than 30 years experience in the process development and manufacturing of biopharmaceuticals produced from yeast, bacterial and mammalian cells. This includes expertise in engineering, technology transfer, manufacturing and clinical development at a number of prominent biotechnology companies including Zymogenetics, Biomira (now Oncothyreon), Protein Design Lab...